Status:
COMPLETED
Nutritional Regulation of Leukocyte Function
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Osato Research Institute
Conditions:
FPP
Fermented Papaya Preparation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the current study is to determine the dose at which Fermented Papaya Preparation ( FPP) is able to improve inducible respiratory burst outcomes in peripheral blood mononuclear cells (...
Detailed Description
Fermented Papaya Preparation (FPP) is a dietary supplement that is available as over-the-counter in the US. FPP possesses antioxidant properties, which provide benefit against age-related complication...
Eligibility Criteria
Inclusion
- Ages 18 and above
- Subjects must be able to follow directions and give informed consent on their own
Exclusion
- • Individuals who are deemed unable to understand the procedures, risks and benefits of the study, ie. Informed consent will be excluded.
- Females who are pregnant will also be excluded to minimize the risk to such individuals (and fetus).
- Individuals who are therapeutically immuno-compromised will also be excluded to decrease statistical variability and to minimize potential of confounders.
- Candidates for inclusion into the study will not include individuals as defined in 45 CFR 46 Subparts B, C and D, nor from any other population which may be considered vulnerable.
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT05191758
Start Date
February 15 2022
End Date
July 31 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Health Methodist Hospital
Indianapolis, Indiana, United States, 46228